Xeloda and Roxicet drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Xeloda (capecitabine) and Roxicet (acetaminophen; oxycodone hydrochloride). Common drug interactions include metastases to bone among females and mucosal inflammation among males.
The phase IV clinical study analyzes what interactions people have when they take Xeloda and Roxicet. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Xeloda?
Xeloda has active ingredients of capecitabine. It is often used in colon cancer. eHealthMe is studying from 46,649 Xeloda users. Check the latest studies of Xeloda.
What is Roxicet?
Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.
26 people who take Xeloda and Roxicet together, and have interactions are studied.

What are the common drug interactions of Xeloda and Roxicet, by gender? *:
female:
- Metastases to bone (cancer spreads to bone)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Hepatic cyst
- Tooth loss
- Anxiety
- Bone pain
- Cellulitis (infection under the skin)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Pain in jaw
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
male:
- Mucosal inflammation (infection of mucous membrane)
- Actinomycotic skin infection (infectious and inflammatory diseases affect the skin and the oral mucosa)
- Back pain
- Bone disorder
- Bone pain
- Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
- Cellulitis (infection under the skin)
- Cervix inflammation
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
What are the common drug interactions of Xeloda and Roxicet, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Acute sinusitis
- Anaemia (lack of blood)
- Anxiety
- Arthralgia (joint pain)
- Bone disorder
- Bone pain
- Cellulitis (infection under the skin)
- Cervix inflammation
- Dental caries
- Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
50-59:
- Emotional distress
- Hepatic cyst
- Infection
- Injury
- Metastases to bone (cancer spreads to bone)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Scar
- Tooth loss
- Gingival swelling (gums swelling)
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
60+:
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
- Exposed bone in jaw
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hepatic steatosis (fatty liver disease)
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Injury
- Intervertebral disc protrusion (spinal disc protrusion)
- Neoplasm progression (growth of tumour)
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 11 people, 42.31%
- Breast Cancer: 7 people, 26.92%
- Anaemia (lack of blood): 7 people, 26.92%
- Breast Cancer Metastatic: 5 people, 19.23%
* Approximation only. Some reports may have incomplete information.
Do you take Xeloda and Roxicet?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Xeloda and Roxicet:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Xeloda:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Roxicet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xeloda and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Roxicet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on capecitabine and acetaminophen; oxycodone hydrochloride (the active ingredients of Xeloda and Roxicet, respectively), and Xeloda and Roxicet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zide cause Rectal Tenesmus? - 3 seconds ago
- Could Ogen cause Vomiting Aggravated? - 3 seconds ago
- Drug interactions of Biaxin and Profen - 9 seconds ago
- Curcumin vs. Acetaminophen, side effect and effectiveness comparison - 13 seconds ago
- Drug interactions of Decadron and Modafinil - 15 seconds ago
- Could Cymbalta cause Metaplasia? - 17 seconds ago
- Could Butalbital And Acetaminophen cause Back Pain? - 23 seconds ago
- Gout and Swelling Face - 24 seconds ago
- Could Triamterene And Hydrochlorothiazide cause Confusion? - 25 seconds ago
- Glucose Tolerance Impaired and Sinusitis - 27 seconds ago